Among estrogen-responsive genes found in previous studies, mRNA levels of SELENBP1, but not other selenium-containing proteins, were found to be down-regulated by estrogen treatment in breast cancer cells [27], [28]. The gene discussed is SELENBP1; the disease is breast carcinoma.